Peregrine Pharmaceuticals financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2014-10-31 3 months ending 2014-07-31 3 months ending 2014-04-30 3 months ending 2014-01-31 3 months ending 2013-10-31
Revenue 6.30 5.50 6.47 3.88 7.35
Other Revenue, Total - - - - -
Total Revenue 6.30 5.50 6.47 3.88 7.35
Cost of Revenue, Total 4.14 3.58 3.83 2.42 4.20
Gross Profit 2.16 1.91 2.65 1.47 3.16
Selling/General/Admin. Expenses, Total 4.29 4.88 4.36 4.56 4.02
Research & Development 10.00 10.20 8.81 6.65 6.96
Depreciation/Amortization - - - - -
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) - - 0.00 0.00 0.00
Other Operating Expenses, Total - - - - -
Total Operating Expense 18.44 18.67 17.00 13.63 15.17
Operating Income -12.14 -13.17 -10.53 -9.74 -7.81
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net - - - - -
Income Before Tax -12.10 -13.13 -10.25 -9.72 -7.79
Income After Tax -12.10 -13.13 -10.25 -9.72 -7.79
Minority Interest - - - - -
Equity In Affiliates - - - - -
Net Income Before Extra. Items -12.10 -13.13 -10.25 -9.72 -7.79
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income -12.10 -13.13 -10.25 -9.72 -7.79
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items -13.13 -14.16 -10.65 -9.72 -7.79
Income Available to Common Incl. Extra Items -13.13 -14.16 -10.65 -9.72 -7.79
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment - - - 0.00 0.00
Diluted Weighted Average Shares 179.96 179.12 176.75 163.22 156.95
Diluted EPS Excluding Extraordinary Items -0.07 -0.08 -0.06 -0.06 -0.05
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue 0.00 0.00 0.00 0.00 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS -0.07 -0.08 -0.06 -0.06 -0.05